IMPACT

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

What's the purpose of the trial?

A randomized placebo controlled, phase 2 study of budesonide in subjects with multiple myeloma undergoing autologous stem cell transplant.

Trial status

Accepting patients

Phase
Phase 2
Enrollment
120
Last Updated
4 months ago
Am I Eligible

Participating Centers

There is one center participating in this trial. Enter a location below to view the distance.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Budesonide
  • Placebo

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

Budesonide EC

Accepting patients

Placebo

Not yet accepting

Budesonide EC

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.